Delivery Order SPE2DB20D1100-SPE2DB25FB8Y1

Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D2211|SPE2DB25FRWLX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568120590 DEXTROAMP-AMPHET ER 20 MG CAP 100S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $1,207.22, and an ultimate completion date of May 5, 2025. It is not designated...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,143.22. The contract provides for the delivery of DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product, with a performance period through June 30, 2025. The contract is not designated as a set-aside....
This federal contract award, valued at $1,601.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567136727 DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product, and has an ultimate completion date of February 4, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not associated with a set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,598.18 delivery order contract is for the supply of 4568097623 - DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product. The contract is a Firm Fixed Price agreement with a performance period through May 2, 2025. No set-aside designation is indicated, suggesting open competition. AmerisourceBergen Drug Corp...
This federal contract award, with ID SPE2DB24D2208|SPE2DB25FHHPT, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order with a firm fixed price for the supply of 4,568,120,543 units of the pharmaceutical product DEXTROAMP-AMPHET ER 20 MG CAP 100S. The award has a ceiling value of $1,757.94 and an ultimate completion date of May 5, 2025. The contract is not set aside and was open for competition. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,163.56 with a Firm Fixed Price pricing type. It provides for the delivery of 4568567882 - DEXTROAMP-AMPHET ER 20 MG CAP 100S, a prescription medication, with a performance period ending on June 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug...
This federal contract award, valued at $1,722.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567458315 DEXTROAMP-AMPHET ER 10 MG CAP 100S, a pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of March 5, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp...
This federal contract award, valued at $1,190.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB24D2100|SPE2DB25FBDRN) for the supply of 4567967859 DEXTROAMP-AMPHET ER 20 MG CAP 100S, with a firm fixed price and an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order worth $2,360.49 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product, with a performance period through May 20, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a $2,053.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4564753993 - DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product, with a period of performance through May 31, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB8Y1
    Delivery Order

This federal contract award, with ID SPE2DB20D1100|SPE2DB25FB8Y1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4568004519 - DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product. The contract has a firm fixed price of $2,721.62 and an ultimate completion date of April 24, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to military healthcare programs. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/23/25, 9:42 AM